BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6052794)

  • 41. [Cerebrospinal fluid protein electrophoresis in neurological practice. Our personal experience].
    Maurin P; Henry P; Neuzil E
    Bord Med; 1970 Feb; 3(2):299-315. PubMed ID: 4193312
    [No Abstract]   [Full Text] [Related]  

  • 42. Liquor-cytological investigations in multiple sclerosis.
    Schmidt RM; Neumann V
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 127(2):237-42. PubMed ID: 6169142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical relationship between mastix reaction and electrophoresis in cerebrospinal fluid].
    Lössner J; Diessner H
    Psychiatr Neurol Med Psychol (Leipz); 1973 Nov; 25(11):689-94. PubMed ID: 4778475
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes in the formula of cerebrospinal fluid in acute cerebral ischemia in particular of the protein fractions].
    Bartko D; Danisová J; Wagnerová M
    Cesk Neurol; 1967 Sep; 30(5):306-14. PubMed ID: 4168774
    [No Abstract]   [Full Text] [Related]  

  • 45. [Significance of oligoclonal proteins and magnetic resonance imaging in the diagnosis of multiple sclerosis].
    Zaborski J; Fiszer U; Kryst-Widźgowska T; Członkowska A; Waliniowska E
    Neurol Neurochir Pol; 1992; 26(4):473-81. PubMed ID: 1484573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative immunochemical studies of cerebrospinal fluid proteins in relation to clinical activity of multiple sclerosis.
    Bauer H; Gottesleben A
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:643-8. PubMed ID: 4190448
    [No Abstract]   [Full Text] [Related]  

  • 47. Multiple sclerosis: a two-phase disease?
    Schuller E; Delasnerie N; Deloche G; Loridan M
    Acta Neurol Scand; 1973; 49(4):453-60. PubMed ID: 4129810
    [No Abstract]   [Full Text] [Related]  

  • 48. [Changes in cerebrospinal fluid proteins in polyneuritis].
    Rieder HP; Kaeser HE; Nusselt L
    Schweiz Med Wochenschr; 1972 Jun; 102(22):766-72. PubMed ID: 4113838
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cerebrospinal fluid analysis in healthy persons and multiple sclerosis patients].
    Arnold F
    Schweiz Med Wochenschr; 1966 Aug; 96(34):1098-103. PubMed ID: 5985859
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative results of agar electrophoresis and electrofocalization examination of gamma globulins of the cerebrospinal fluid].
    Delmotte P
    Acta Neurol Belg; 1972; 72(4):226-34. PubMed ID: 4120106
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cerebrospinal fluid proteins in multiple sclerosis].
    Dupelj M; Hamel-Puskarić N; Arko K
    Neuropsihijatrija; 1966; 14(1):51-7. PubMed ID: 5191198
    [No Abstract]   [Full Text] [Related]  

  • 52. [A rapid and simple nephelometric assay for total protein in cerebrospinal fluid (author's transl)].
    Reiber H
    J Clin Chem Clin Biochem; 1980 Feb; 18(2):123-7. PubMed ID: 7373236
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of the functional state of the blood-brain barrier by means of the analysis of total protein, albumin level and albumin index of the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(5):465-71. PubMed ID: 7453918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The C.S.F. protein formula in central nervous system diseases and especially in multiple sclerosis. Study of 218 examinations].
    Bizouard P; Guisard D; André JM; Arnould G
    Sem Hop; 1970 Jul; 46(31):2151-62. PubMed ID: 4195397
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cerebrospinal fluid and serum protein analysis in multiple sclerosis by electroimmunoassay and single radial immunodiffusion method].
    Saku A
    Rinsho Shinkeigaku; 1975 Apr; 15(4):184-90. PubMed ID: 806412
    [No Abstract]   [Full Text] [Related]  

  • 56. [Multiple sclerosis and disseminated encephalomyelitis. Differences in clinical and biochemical findings].
    Cernácek J; Varsik P; Ujházyová-Králiková D; Wagnerová M
    Cesk Neurol; 1973 Mar; 36(2):77-83. PubMed ID: 4689276
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chemical analysis of cerebrospinal fluid--recent progress (author's transl)].
    Sasaki T
    Rinsho Byori; 1979 Jun; 27(6):459-66. PubMed ID: 470171
    [No Abstract]   [Full Text] [Related]  

  • 58. [Importance and significance of electrophoretic changes in serum and cerebrospinal-fluid proteins in multiple sclerosis].
    Morariu M; Grecu F
    Stud Cercet Neurol; 1970; 15(4):231-8. PubMed ID: 4098631
    [No Abstract]   [Full Text] [Related]  

  • 59. [Multiple sclerosis in Cantabria. Retrospective study of 30 cases].
    Miró J; Rebollo M; Combarros O; Polo JM; Leno C; Berciano J
    Rev Clin Esp; 1984 Nov 15-30; 175(3-4):153-6. PubMed ID: 6531481
    [No Abstract]   [Full Text] [Related]  

  • 60. Cerebrospinal fluid complement in multiple sclerosis.
    Dube VE; McDuffie FC; Burton RC; Ilstrup D
    J Lab Clin Med; 1973 Apr; 81(4):530-7. PubMed ID: 4121212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.